Immunomodulation of hdac inhibitor entinostat potentiates the anticancer effects of radiation and pd-1 blockade in the murine lewis lung carcinoma model

HIGHLIGHTS

• who: Yeeun Kim and colleagues from the Department of Radiation Oncology, Samsung Medical Center, Seoul, Republic of Korea Department of Radiation Oncology, Sungkyunkwan University School of Medicine have published the article: Immunomodulation of HDAC Inhibitor Entinostat Potentiates the Anticancer Effects of Radiation and PD-1 Blockade in the Murine Lewis Lung Carcinoma Model, in the Journal: (JOURNAL) of 18/Oct/2019
• what: The authors showed that the histone deacetylase inhibitor entinostat potentiated the efficacy of radiotherapy and anti-PD-1 using a murine syngeneic LL/2 tumor model.
• how: The authors investigated whether . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.